HK1093012172
HK1093012172
CSPC PHARMA
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 26.005.980.000 | 29.009.254.000 | 10.4% |
| Cost of Revenue | 8.947.477.000 | 8.710.543.000 | 2.7% |
| Gross Profit | 17.058.503.000 | 20.298.711.000 | 16.0% |
| 12.877.203.000 | 14.820.097.000 | 13.1% | |
| Operating Income | 4.181.300.000 | 5.478.614.000 | 23.7% |
| Pretax Income | 4.808.117.000 | 5.578.726.000 | 13.8% |
| Net Income Common Stockholders | 3.882.108.000 | 4.328.035.000 | 10.3% |
| -- | -- | -- | |
| -- | -- | -- |